Tomoda Y, Miwa T, Ishizuka N
J Clin Endocrinol Metab. 1975 Apr;40(4):644-51. doi: 10.1210/jcem-40-4-644.
A radioligand receptor assay system for urinary hCG and serum hCG was developed, using 1100-2000 times g fractions of homogenates of pig testis. This method is specific for hCG and LH, and the limit of detection for hCG was 20 mIU, which could be significantly discriminated from zero at the 95% confidence level. A nonspecific inhibition reaction which exerts its influence on the assay system has been found in the urine and serum, and in performing assays for urinary and serum hCG, it was necessary to remove the inhibition reaction by diluting the urine more than eight fold or subject the serum to an extraction procedure. Since the hCG of normal pregnancy and trophoblastic neoplasia showed a dose response curve similar to that of the International Standard hCG, it became clear that these hCG could be assayed with this method. The potency ratio R/I measured by RRA and RIA of urinary hCG and serum hCG was different from those of normal pregnancy and trophoblastic neoplasia.
利用猪睾丸匀浆1100 - 2000倍重力沉降组分,开发了一种用于检测尿hCG和血清hCG的放射性配体受体分析系统。该方法对hCG和LH具有特异性,hCG的检测限为20 mIU,在95%置信水平下可与零显著区分。在尿液和血清中发现了一种对分析系统有影响的非特异性抑制反应,在进行尿hCG和血清hCG检测时,有必要通过将尿液稀释8倍以上或对血清进行提取程序来消除抑制反应。由于正常妊娠和滋养细胞肿瘤的hCG显示出与国际标准hCG相似的剂量反应曲线,因此很明显这些hCG可用该方法进行检测。通过RRA和RIA测定的尿hCG和血清hCG的效价比R/I与正常妊娠和滋养细胞肿瘤的不同。